Crystal Escano

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose The TLR 7/8 agonist, Resiquimod has been shown to induce local activation of immune cells, production of cytokines, and antigen-presentation by dendritic cells, features desirable for cancer vaccine adjuvants. In this study, we evaluated the safety and immunogenicity of vaccination with NY-ESO-1 protein emulsified in Mon-tanide ISA-51 VG when given(More)
  • 1